Aug142024Zolbetuximab Approved to Treat Adults with Stomach or Gastro-oesophageal Junction Cancer HM Government TwitterLinkedinFacebookemailZolbetuximab (Vyloy) is a monoclonal antibody that can recognise and attach itself to certain cancer cells to destroy them. Follow this news feed: